Doxycycline Postexposure Prophylaxis (DoxyPEP) for Bacterial STI Prevention

Muhammad H Junejo; Julia L Marcus; Kenneth A Katz

doi:10.1001/jamadermatol.2024.4567

Doxycycline Postexposure Prophylaxis (DoxyPEP) for Bacterial STI Prevention

JAMA Dermatol. 2025 Jan 1;161(1):7-8. doi: 10.1001/jamadermatol.2024.4567.

Authors

Muhammad H Junejo¹, Julia L Marcus^{2

3}, Kenneth A Katz⁴

Affiliations

¹ Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
² Harvard Medical School, Boston, Massachusetts.
³ Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
⁴ Department of Dermatology, Kaiser Permanente San Francisco Medical Center, San Francisco, California.

PMID: 39535772
DOI: 10.1001/jamadermatol.2024.4567

No abstract available

Plain language summary

This Viewpoint describes what dermatologists should know about doxycycline postexposure prophylaxis (doxyPEP) for bacterial sexually transmitted infection (STI) prevention, specifically syphilis, chlamydia, and gonorrhea.